Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Complete Response -- New Partnership Deal???

<< Previous

Bullboard Posts

Next >>

Post by CarbonWarrioron Nov 22, 2022 11:36am

192 Views

Post# 35118845

Complete Response -- New Partnership Deal???

More results will come out on Dec 7 for the nerds to digest.

It's only a matter of time before ONC gets a deal here.
As for cash, ADLAI will give some 21Millions USD soon. So, the future here is quite bright.

Again we have a Complete Response here folks at week 24 - patient 013 (lucky 13!!!!)

A 65 year old gentlemen. Sir, live on and live long !!!!

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects